Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

The burden forecast of injuries caused by fire, heat, and hot substances for 2021–2030. by Shi Huang (125861)

Subjects:

Frontier analysis of injuries’ burden caused by fire, heat, and hot substances from 1990 to 2021. by Shi Huang (125861)

Subjects:

Burden of injuries caused by fire, heat, and substances in Incidence, Prevalence and Death between 1990 and 2021. by Shi Huang (125861)

Subjects:

The burden of injuries caused by fire, heat and hot substances in female and male across 22 GBD regions. by Shi Huang (125861)

Subjects:

Graph of successive trends in the burden of injury caused by fire, heat and hot substances between 1990 and 2021. by Shi Huang (125861)

Subjects:

Frontier Analysis: Countries with high potential for improvement in the burden of injuries caused by fire, heat, and hot substances in 2021. by Shi Huang (125861)

Subjects:

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”

Predictions of Age-Standardized Rate of burden caused by fire, heat and hot substances for different sexes in 2030 based on the Bayesian Age-Period-Cohort model. by Shi Huang (125861)

Subjects:

Burden of injuries caused by fire, heat, and substances in Disability-Adjusted Life Years, Years of Life Lost and Years Lived with Disability between 1990 and 2021. by Shi Huang (125861)

Subjects:

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Subjects:

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Subjects:

Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

Subjects:

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”

Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. by Jiefeng Zhao (9090305)

Subjects:

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)

Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects: